Ectopic Cervical Thymic Tissue Mimicking Parathyroid Hyperplasia: A Rare Occurrence Linked to Graves Disease Authors: Waralee Chatchomchuan, Yotsapon Thewjitcharoen, Soontaree Nakasatien, Ronnarat Suvikapakornkul, Somboon Keerawat, Thep Himathongkam Published: 2024 ABSTRACT AbstractThymic hyperplasia has occasionally been reported in patients with Graves disease (GD). However, ectopic cervical thymic hyperplasia in the setting of hyperthyroid GD is exceptionally rare. We describe a case of a 54-year-old Thai woman who presented with hyperthyroidism, diplopia, and pretibial myxedema. She underwent a total thyroidectomy because of diplopia caused by Graves ophthalmopathy. During the surgery, 3 macroscopically abnormal enlargements of parathyroid gland-like tissue were identified and removed. Histopathology revealed hyperplastic thymic tissue mixed with 1 normal-sized parathyroid gland at the location of the left upper parathyroid gland, and thymic tissue was found in the sample labeled as the right upper parathyroid gland. Notably, the sample labeled as the right lower parathyroid gland was actually determined to be a lymph node. Preoperative blood samples showed normal serum calcium and parathyroid hormone levels. Postoperatively, computed tomography of the chest showed thymic hyperplasia in the anterior mediastinum, which slightly regressed at the 9-month follow-up. The patient had transient hypoparathyroidism requiring oral calcium and active vitamin D supplements for 6 months postoperatively. Ectopic cervical thymic hyperplasia can be found in GD and might be indistinguishable from parathyroid hyperplasia. Biochemical evaluations are required to exclude concomitant hyperparathyroidism, and a conservative approach should be considered.Keywords: ectopic cervical thymic tissue, thymic hyperplasia, parathyroid hyperplasia, mimicking, Graves disease Introduction Ectopic cervical thymus is a rare congenital anomaly in adults, resulting from the aberrant migration of the embryonic thymus from the superior neck to the mediastinum [1, 2]. Various pathologies can be identified in ectopic thymus, including thymic hyperplasia secondary to Graves disease (GD) [3-5]. The exact mechanism of thymic hyperplasia associated with GD is not yet understood, but it is hypothesized to stem from the presence of thyrotropin receptors in thymic tissue [6, 7]. GD is associated with both epithelial and lymphoid hyperplasia of the thymus because of stimulation by both thyrotropin receptor antibody (TRAb) and thyroid hormone [8]. This condition is typically benign and improves with treatment of GD [8, 9]. Therefore, a conservative approach should be considered when encountering thymic hyperplasia associated with GD. Unexpectedly enlarged parathyroid glands (incidentalomas) can occasionally be found during thyroid surgery [10]. There is considerable controversy over whether these abnormal parathyroid glands should be excised and sent for histological analysis. The risk of permanent hypoparathyroidism should be weighed against the potential for functioning parathyroid glands or malignant lesions. Here, we present a rare case of ectopic cervical thymic hyperplasia associated with GD, which was mistaken for parathyroid hyperplasia during thyroid surgery for GD. Case Presentation A 54-year-old Thai woman with a 1-year history of GD presented with diplopia and pretibial myxedema, as shown in Fig. 1. After 6 months, her hyperthyroidism was controlled with methimazole 10 mg per day, but her diplopia worsened, leading to the development of severe Graves ophthalmopathy. She had neither muscular nor ocular weakness. Her serum TRAb levels were very high, measuring >40 IU/L (normal value <1.75 IU/L). She underwent a total thyroidectomy because of the severity of her Graves ophthalmopathy. (A) Exophthalmos in both eyes and an inability to look upward with the right eye. (B) Plaques of thick, orange-peel texture, known as pretibial myxedema, present on both shins. Diagnostic Assessment Preoperatively, laboratory tests showed a TSH level of <0.01 µIU/mL (<0.01 mIU/L) (normal range: 0.27-4.20 µIU/mL; 0.27-4.20 mIU/L), total triiodothyronine at 95 ng/dL (1.46 nmol/L) (normal range: 61-177 ng/dL; 0.94-2.72 nmol/L), and free thyroxine at 1.2 ng/dL (15.4 pmol/L) (normal range: 0.9-1.7 ng/dL; 11.6-21.9 pmol/L). The preoperative chest X-ray was normal. No thyroid ultrasonography or serum calcium level was assessed before surgery. The patient then underwent a total thyroidectomy. During the surgery, both upper parathyroid glands and the right lower parathyroid gland were observed to be macroscopically enlarged. The surgeon, a high-volume thyroid specialist, decided to remove them because of concern for parathyroid hyperplasia, as shown in Fig. 2A. Histopathological examination revealed diffuse hyperplastic thyroid follicles consistent with GD. Unexpectedly, the resected presumed parathyroid tissues showed hyperplastic thymic tissue mixed with 1 normal-sized parathyroid gland at the location of the left upper parathyroid gland, as shown in Fig. 2B. Conversely, only thymic hyperplasia was observed at the site of the right upper parathyroid gland, with a lymph node identified at the location of the right lower parathyroid gland. Additionally, 2 other normal parathyroid glands were found within the thyroid. No malignant cells were identified in the thymic tissues. These findings were consistent with ectopic cervical thymic hyperplasia. Serum calcium, serum intact PTH (iPTH), and serum vitamin D were subsequently measured immediately after the operation, using the preoperative serum samples. Serum calcium was 9.1 mg/dL (2.27 mmol/L) (normal range: 8.6-10.0 mg/dL; 2.14-2.49 mmol/L), serum iPTH was 52.1 pg/mL (5.52 pmol/L) (normal range: 15.0-65.0 mg/dL; 1.59-6.89 pmol/L), and serum vitamin D was 28 ng/mL (70 nmol/L). (A) Gross examination of the enlarged thyroid gland weighed 60 g, enlarged resected parathyroid glands (left upper parathyroid gland measuring 1.5 × 1.1 × 0.4 cm; right upper parathyroid gland measuring 1.0 × 0.6 × 0.2 cm; right lower parathyroid gland measuring 0.8 × 0.7 × 0.5 cm), and resected thymus gland. (B) Histopathological examination of the specimens revealed hyperplastic thymic tissue admixed with 1 normal-sized parathyroid gland in the location of left upper parathyroid gland. P, parathyroid gland; T, thymic tissue containing Hassall corpuscles (arrow). Treatment The patient developed hypocalcemia postoperatively, with serum calcium at 7.9 mg/dL (1.97 mmol/L), serum albumin 3.6 g/dL (36 g/L), and serum iPTH at 2.8 pg/mL (0.29 pmol/L), requiring IV calcium and oral active vitamin D. Three months after surgery, the patient continued to experience mild hypocalcemia, necessitating daily oral calcium carbonate (1500 mg) and oral calcitriol (0.25 µg). Computed tomography (CT) of the chest revealed a mediastinal soft tissue mass consistent with thymic hyperplasia, as shown in Fig. 3A. (A) Axial view from chest computed tomography (CT) at 3 months postoperatively showed thymic hyperplasia (arrow). (B) Follow-up chest CT 9 months later showed regression of thymic hyperplasia (arrow). There is no mediastinal or hilar lymphadenopathy. Outcome and Follow-up At the 6-month postoperative follow-up, the patient recovered from hypocalcemia and no longer required oral calcium or active vitamin D. A repeat chest CT at 9 months postthyroidectomy showed a significant reduction in the mediastinal thymic tissue, as depicted in Fig. 3B. Discussion Aberrant thymic tissue in the neck, resulting from failed thymic descent during the second month of pregnancy, may be found in up to one third of infants. Typically, this thymic tissue gradually transforms into fatty tissue and disappears within the first few years of life [11]. Ectopic cervical thymus may exhibit the same pathologies as mediastinal thymus, such as thymoma, thymic hyperplasia, and thymic cysts. Ectopic cervical thymic hyperplasia has been reported in very few cases in the setting of hyperthyroid GD and might be indistinguishable from parathyroid tissue [3-5]. Moreover, simultaneous thymic and parathyroid tissue can be found in perithyroid adipose tissue because of the close anatomical and embryological relationship between the parathyroid gland and thymus [3]. Both tissues derive from the third pharyngeal pouch and migrate to their respective anatomical positions [1]. Thymic hyperplasia associated with GD has been increasingly recognized in the past decade, often detected incidentally during routine imaging for other pathologies [9]. This phenomenon might be linked to elevated levels of TRAb and thyroid hormones. Although the TSH receptor is also present in the thymus gland, its expression there is typically 5 to 50 times lower than in the thyroid gland [10]. Animal studies have shown that administering thyroid hormone can increase the number of the thymus epithelial cells [8]. In humans, there has been a report of thymic hyperplasia associated with thyroiditis, suggesting that the link is not only related to TRAb but also to thyroid hormone [12]. In most cases, the thymic mass resolves within 2 years once a euthyroid state is achieved [7]. In exceedingly rare cases, neoplasms such as thymoma must be considered if the mass does not regress after several years of euthyroidism [5]. Therefore, the necessity for pathological diagnosis depends on the potential for malignant transformation. In the present case, the diagnosis of ectopic cervical thymic hyperplasia might have been suspected earlier if a thorough thyroid ultrasonography had been performed preoperatively to detect any concomitant pathologies apart from GD. Up to 5% of unsuspected macroscopically abnormal parathyroid glands have been reported during thyroid surgery [11]. The decision to remove a presumed pathological gland or leave it in situ until complete assessments can be conducted must be balanced by the surgeon on a case-by-case basis. The primary complication from removing the gland is permanent postoperative hypoparathyroidism, requiring lifelong calcium and active vitamin D replacement. Intraoperative iPTH and serum calcium measurement can help ascertain hyperparathyroidism associated with the enlarged gland. However, nonfunctioning parathyroid carcinoma or abnormal thymic tissue fused with a normal parathyroid gland, a frozen section may also be helpful for immediate intraoperative assessment to guide surgical decisions [13]. Preoperative diagnosis of ectopic cervical thymic hyperplasia is challenging, but certain unique ultrasonographic features, such as a hypoechoic pattern with multiple linear and punctate bright internal echoes representing connective septa- and intraseptal blood vessels, should raise suspicion of thymic tissue [14]. Fine needle aspiration can provide clues suggestive of thymic hyperplasia if fibrous septa, Hassall corpuscles, and other characteristics of normal thymic architecture are identified on cytology [15]. Magnetic resonance imaging and scintigraphy with thallium-201 or technetium-99 can differentiate ectopic cervical thymic hyperplasia from other conditions better than CT by detecting the capsules and septal walls within the thymus [16, 17]. In conclusion, this case highlights the importance of considering ectopic cervical thymic hyperplasia when macroscopically abnormal parathyroid glands are encountered during thyroidectomy for GD, especially in patients with very high TRAb levels. A conservative approach should be considered, and biochemical evaluations are required to exclude concomitant hyperparathyroidism. Ectopic cervical thymic hyperplasia is a rare differential diagnosis that can be mistaken for parathyroid adenoma or hyperplasia. Learning Points Although rare, ectopic cervical thymic hyperplasia-associated GD could be encountered at the time of thyroid surgery and could be mistaken as parathyroid hyperplasia. Although rare, ectopic cervical thymic hyperplasia-associated GD could be encountered at the time of thyroid surgery and could be mistaken as parathyroid hyperplasia. Intraoperative iPTH and calcium measurement before manipulation of the parathyroid gland, along with biopsy using frozen section would help to ascertain whether these patients had hyperparathyroidism-associated with the enlarged gland. Intraoperative iPTH and calcium measurement before manipulation of the parathyroid gland, along with biopsy using frozen section would help to ascertain whether these patients had hyperparathyroidism-associated with the enlarged gland. Recognition of the association between thymic hyperplasia and GD and its benign course after treatment of the hyperthyroidism can spare patients from unnecessary invasive investigations and a major surgical procedure. Recognition of the association between thymic hyperplasia and GD and its benign course after treatment of the hyperthyroidism can spare patients from unnecessary invasive investigations and a major surgical procedure. Acknowledgments The authors appreciate the guidance and thoughtful suggestions from Professor Rajata Rajatanavin, Mahidol University, for his valuable guidance in the preparation of this case report. The authors also thank Dr. Tinapa Himathongkam for language editing. Part of this work has been presented as a poster at the 12th Seoul International Congress of Endocrinology and Metabolism (SICEM2024), Seoul, Korea. Abbreviations computed tomography Graves disease intact parathyroid hormone thyrotropin receptor antibody Contributor Information Waralee Chatchomchuan, Theptarin Diabetes, Thyroid, and Endocrine center, Vimut-Theptarin Hospital, Bangkok 10110, Thailand. Yotsapon Thewjitcharoen, Theptarin Diabetes, Thyroid, and Endocrine center, Vimut-Theptarin Hospital, Bangkok 10110, Thailand. Soontaree Nakasatien, Theptarin Diabetes, Thyroid, and Endocrine center, Vimut-Theptarin Hospital, Bangkok 10110, Thailand. Ronnarat Suvikapakornkul, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand. Somboon Keerawat, Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Thep Himathongkam, Theptarin Diabetes, Thyroid, and Endocrine center, Vimut-Theptarin Hospital, Bangkok 10110, Thailand. Contributors W.C. and Y.T. contributed to manuscript preparation and submission. S.N. contributed to the manuscript and graphic preparation. R.S. and S.K. contributed to the diagnosis and management of the patient and manuscript preparation. S.K. and T.H. contributed to the discussions. All authors reviewed and approved the final draft. Funding No public or commercial funding. Disclosures None declared. Informed Patient Consent for Publication Signed informed consent was obtained directly from the patient. Data Availability Statement Data sharing is not applicable to this article as no data sets were generated or analyzed during the present study. References Associated Data Data Availability Statement Data sharing is not applicable to this article as no data sets were generated or analyzed during the present study.